Report Detail
Global Endocrinology Drugs Market Insights, Forecast to 2025
- RnM2817060 |
- 16 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
One of the market drivers is increase in prevalence of endocrine hormone-related diseases.
The global Endocrinology Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Endocrinology Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Endocrinology Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Endocrinology Drugs in these regions.
This research report categorizes the global Endocrinology Drugs market by top players/brands, region, type and end user. This report also studies the global Endocrinology Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Market size by Product
Diabetes Drugs
Testosterone Replacement Drugs
Human Growth Hormone Drugs
Thyroid Hormone Disorder Drugs
Market size by End User
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Endocrinology Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Endocrinology Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Endocrinology Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Endocrinology Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Endocrinology Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Endocrinology Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Endocrinology Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Endocrinology Drugs Market Size Growth Rate by Product
- 1.4.2 Diabetes Drugs
- 1.4.3 Testosterone Replacement Drugs
- 1.4.4 Human Growth Hormone Drugs
- 1.4.5 Thyroid Hormone Disorder Drugs
- 1.5 Market by End User
- 1.5.1 Global Endocrinology Drugs Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Commercial Laboratories
- 1.5.4 Ambulatory Care Centres
- 1.5.5 Other Setting
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Endocrinology Drugs Market Size
- 2.1.1 Global Endocrinology Drugs Revenue 2014-2025
- 2.1.2 Global Endocrinology Drugs Sales 2014-2025
- 2.2 Endocrinology Drugs Growth Rate by Regions
- 2.2.1 Global Endocrinology Drugs Sales by Regions
- 2.2.2 Global Endocrinology Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Endocrinology Drugs Sales by Manufacturers
- 3.1.1 Endocrinology Drugs Sales by Manufacturers
- 3.1.2 Endocrinology Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Endocrinology Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Endocrinology Drugs Revenue by Manufacturers
- 3.2.1 Endocrinology Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Endocrinology Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Endocrinology Drugs Price by Manufacturers
- 3.4 Endocrinology Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Endocrinology Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Endocrinology Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Endocrinology Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Endocrinology Drugs Sales by Product
- 4.2 Global Endocrinology Drugs Revenue by Product
- 4.3 Endocrinology Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Endocrinology Drugs Breakdown Data by End User
6 North America
- 6.1 North America Endocrinology Drugs by Countries
- 6.1.1 North America Endocrinology Drugs Sales by Countries
- 6.1.2 North America Endocrinology Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Endocrinology Drugs by Product
- 6.3 North America Endocrinology Drugs by End User
7 Europe
- 7.1 Europe Endocrinology Drugs by Countries
- 7.1.1 Europe Endocrinology Drugs Sales by Countries
- 7.1.2 Europe Endocrinology Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Endocrinology Drugs by Product
- 7.3 Europe Endocrinology Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Endocrinology Drugs by Countries
- 8.1.1 Asia Pacific Endocrinology Drugs Sales by Countries
- 8.1.2 Asia Pacific Endocrinology Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Endocrinology Drugs by Product
- 8.3 Asia Pacific Endocrinology Drugs by End User
9 Central & South America
- 9.1 Central & South America Endocrinology Drugs by Countries
- 9.1.1 Central & South America Endocrinology Drugs Sales by Countries
- 9.1.2 Central & South America Endocrinology Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Endocrinology Drugs by Product
- 9.3 Central & South America Endocrinology Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Endocrinology Drugs by Countries
- 10.1.1 Middle East and Africa Endocrinology Drugs Sales by Countries
- 10.1.2 Middle East and Africa Endocrinology Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Endocrinology Drugs by Product
- 10.3 Middle East and Africa Endocrinology Drugs by End User
11 Company Profiles
- 11.1 AbbVie
- 11.1.1 AbbVie Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AbbVie Endocrinology Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AbbVie Endocrinology Drugs Products Offered
- 11.1.5 AbbVie Recent Development
- 11.2 AstraZeneca
- 11.2.1 AstraZeneca Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AstraZeneca Endocrinology Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AstraZeneca Endocrinology Drugs Products Offered
- 11.2.5 AstraZeneca Recent Development
- 11.3 Eli Lilly
- 11.3.1 Eli Lilly Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Eli Lilly Endocrinology Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Eli Lilly Endocrinology Drugs Products Offered
- 11.3.5 Eli Lilly Recent Development
- 11.4 Merck
- 11.4.1 Merck Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck Endocrinology Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck Endocrinology Drugs Products Offered
- 11.4.5 Merck Recent Development
- 11.5 Novo Nordisk
- 11.5.1 Novo Nordisk Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Novo Nordisk Endocrinology Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Novo Nordisk Endocrinology Drugs Products Offered
- 11.5.5 Novo Nordisk Recent Development
- 11.6 Sanofi
- 11.6.1 Sanofi Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sanofi Endocrinology Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sanofi Endocrinology Drugs Products Offered
- 11.6.5 Sanofi Recent Development
12 Future Forecast
- 12.1 Endocrinology Drugs Market Forecast by Regions
- 12.1.1 Global Endocrinology Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Endocrinology Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Endocrinology Drugs Market Forecast by Product
- 12.2.1 Global Endocrinology Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Endocrinology Drugs Revenue Forecast by Product 2019-2025
- 12.3 Endocrinology Drugs Market Forecast by End User
- 12.4 North America Endocrinology Drugs Forecast
- 12.5 Europe Endocrinology Drugs Forecast
- 12.6 Asia Pacific Endocrinology Drugs Forecast
- 12.7 Central & South America Endocrinology Drugs Forecast
- 12.8 Middle East and Africa Endocrinology Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Endocrinology Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Endocrinology Drugs . Industry analysis & Market Report on Endocrinology Drugs is a syndicated market report, published as Global Endocrinology Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Endocrinology Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
